Sr. Account Manager, Michigan-Indiana; Galafold & Pombiliti Opfolda)

Bio Marin is a leading rare disease biotechnology company focused on genetically defined conditions.

Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered a portfolio of therapies since our founding in 1997. Our revolutionary treatments for conditions like achondroplasia (the most common form of dwarfism), PKU (phenylketonuria), CLN2, a form of Batten disease, and a number of forms of MPS (mucopolysaccharidosis) offer new possibilities for patients and families who previously had few, if any, available options.

More recently, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease, expanding our ability to reach more people living with rare genetic conditions.

Our success comes from our unwavering commitment to excellence, our deep understanding of patient needs, our scientific expertise, and our world-class manufacturing capabilities. At the heart of Bio Marin is a dedicated team of the brightest minds in the industry working together to deliver innovative therapies to patients and families around the world.

Be part of the worldwide infrastructure that gets our drugs to underserved patients around the world. Our global sales force solidifies Bio Marin’s commercial presence in the United States and Europe and is rapidly growing in other regions, such as South America, EuMEA, and Asia-Pacific.

Ideal location:
Metro Detroit, Metro Grand Rapids

Reporting to:
Sales Director, Enzyme Therapies

The Sr. Account Manager (SAM) is a field-based commercial leader responsible for driving demand, accelerating patient identification, and ensuring optimal treatment for patients eligible for Galafold® and Pombiliti Opfolda across the Michigan-Indiana area. The Sr. Account Manager will have direct responsibility representing Bio Marin products to medical professionals who specialize in the treatment of Fabry and Pompe disease.

This role operates at the forefront of Bio Marin’s go-to-market strategy for rare diseases, serving as the primary point of engagement with healthcare providers (HCPs) and key accounts. The SAM translates brand and franchise strategy into territory-level execution, delivering strong business performance while maintaining a deep commitment to patient impact.

As part of the U.S. Enzyme Therapies (ET) commercial organization, the SAM partners closely with Clinical Coordinators, Market Access, Medical Affairs, and Marketing to deliver an integrated customer experience and maximize outcomes across the treatment journey.

• Develop and execute a comprehensive territory business plan aligned with brand strategy and franchise priorities
• Drive demand generation across target HCP segments (e.g., geneticists, cardiologists, neurologists, metabolic specialists)
• Prioritize accounts using data-driven insights to optimize impact
• Deliver against sales objectives and key performance indicators (KPIs) for both Galafold and Pombiliti Opfolda

• Build and maintain strong, trust-based relationships with key customers and accounts
• Deliver high-quality, compliant product education aligned with approved messaging
• Engage customers across the patient journey, including diagnosis, treatment initiation, and long-term management
• Identify and address barriers to treatment, partnering cross-functionally to resolve access and operational challenges

• Drive initiatives to improve diagnosis and patient finding in Fabry and Pompe diseases
• Collaborate with stakeholders to expand…